194 related articles for article (PubMed ID: 23604714)
1. Smooth muscle-selective CPI-17 expression increases vascular smooth muscle contraction and blood pressure.
Su W; Xie Z; Liu S; Calderon LE; Guo Z; Gong MC
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H104-13. PubMed ID: 23604714
[TBL] [Abstract][Full Text] [Related]
2. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.
Pang H; Guo Z; Su W; Xie Z; Eto M; Gong MC
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C352-60. PubMed ID: 15814590
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction.
Tsai MH; Jiang MJ
Pflugers Arch; 2006 Nov; 453(2):223-32. PubMed ID: 16953424
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697.
Wilson DP; Susnjar M; Kiss E; Sutherland C; Walsh MP
Biochem J; 2005 Aug; 389(Pt 3):763-74. PubMed ID: 15823093
[TBL] [Abstract][Full Text] [Related]
6. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.
Kitazawa T; Eto M; Woodsome TP; Brautigan DL
J Biol Chem; 2000 Apr; 275(14):9897-900. PubMed ID: 10744661
[TBL] [Abstract][Full Text] [Related]
7. Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure.
Qiao YN; He WQ; Chen CP; Zhang CH; Zhao W; Wang P; Zhang L; Wu YZ; Yang X; Peng YJ; Gao JM; Kamm KE; Stull JT; Zhu MS
J Biol Chem; 2014 Aug; 289(32):22512-23. PubMed ID: 24951589
[TBL] [Abstract][Full Text] [Related]
8. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
[TBL] [Abstract][Full Text] [Related]
9. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms.
Eto M; Kitazawa T; Yazawa M; Mukai H; Ono Y; Brautigan DL
J Biol Chem; 2001 Aug; 276(31):29072-8. PubMed ID: 11397799
[TBL] [Abstract][Full Text] [Related]
10. Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.
Reho JJ; Zheng X; Asico LD; Fisher SA
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1039-50. PubMed ID: 25724497
[TBL] [Abstract][Full Text] [Related]
11. Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells.
Pang H; Guo Z; Xie Z; Su W; Gong MC
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C892-9. PubMed ID: 16267107
[TBL] [Abstract][Full Text] [Related]
12. Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo.
Mizuno Y; Isotani E; Huang J; Ding H; Stull JT; Kamm KE
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C358-64. PubMed ID: 18524939
[TBL] [Abstract][Full Text] [Related]
13. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T
Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888
[TBL] [Abstract][Full Text] [Related]
14. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
Dimopoulos GJ; Semba S; Kitazawa K; Eto M; Kitazawa T
Circ Res; 2007 Jan; 100(1):121-9. PubMed ID: 17158339
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3',4'-dihydroxyflavonol on vascular contractions of rat aortic rings.
Song MJ; Baek I; Seo M; Kim SH; Suk K; Woodman OL; Williams SJ; Kim IK
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):803-10. PubMed ID: 20374259
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17.
Stevenson AS; Matthew JD; Eto M; Luo S; Somlyo AP; Somlyo AV
FEBS Lett; 2004 Dec; 578(1-2):73-9. PubMed ID: 15581619
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle.
Kitazawa T; Eto M; Woodsome TP; Khalequzzaman M
J Physiol; 2003 Feb; 546(Pt 3):879-89. PubMed ID: 12563012
[TBL] [Abstract][Full Text] [Related]
18. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.
Eto M; Kitazawa T; Brautigan DL
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8888-93. PubMed ID: 15184667
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Cpi-17 and zipper-interacting protein kinase in the regulation of protein kinase C-alpha, protein kinase C-epsilon on vascular calcium sensitivity after hemorrhagic shock.
Xu J; Yang G; Li T; Ming J; Liu L
Shock; 2010 Jan; 33(1):49-55. PubMed ID: 19373133
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase.
Deng JT; Sutherland C; Brautigan DL; Eto M; Walsh MP
Biochem J; 2002 Oct; 367(Pt 2):517-24. PubMed ID: 12144526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
